Raybow (Suzhou) Pharmaceutical Co., Ltd., Suzhou, China – FDA Inspections

Inspection records and compliance data for Raybow (Suzhou) Pharmaceutical Co., Ltd. in Suzhou. 4 FDA inspections on record, last inspected May 22, 2025.

Company Profile

This profile covers Raybow (Suzhou) Pharmaceutical Co., Ltd. based in Suzhou, China.

FDA Inspection History

FDA inspections: 4
OAI: 0
VAI: 0
NAI: 3
Unclassified: 1
Form 483s: 0
Warning letters: 0

First inspected May 25, 2010. Last inspected May 22, 2025.

FDA inspections (4)

Date	Result	FDA center(s)	Insp. #
May 22, 2025	Not classified	Human Drugs	1273595
October 18, 2018	NAI	Human Drugs · Drug Quality Assurance	1071681
September 19, 2014	NAI	Human Drugs · Drug Quality Assurance	910769
May 25, 2010	NAI	Human Drugs · Drug Quality Assurance	671664

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Weifang Shengtai Medicine Co., Ltd.

Anhui Fengle Perfume Co., Ltd.

Ruyuan Hec Pharm Co. Ltd.

Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd

Hunan Er-Kang Pharmaceutical Co., Ltd.

Shandong Topscience Bio-Tech Co., Ltd.

Zhejiang Raybow Pharmaceutical Co., Ltd.

Hebei Meishen Technology Co., Ltd.

Zhongfu Pharmaceutical Co., Ltd.

Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd.